Send us a Text Message.

Dr. Oren Milstein, Ph.D. is CEO and Board Member of StemRad ( https://stemrad.com/ ), a world leader in the provision of personal radiation protection solutions and is the first company to offer life-saving protection from penetrating ionizing radiation and is making the lives of first responders, military personnel, utility personnel, medical teams, and astronauts safer without compromising mission objectives. Comprised of radiation biology experts, nuclear physicists, designers, and engineers and backed by dozens of prominent doctors and scientists including three Nobel Laureates, StemRad provides cutting-edge technology to protect these heroes on Earth and beyond.

Dr. Milstein co-founded StemRad in 2011, shortly after the Fukushima Daiichi nuclear disaster in Japan. He has been leading R&D efforts ever since and was appointed CEO in February of 2016.

Dr. Milstein has more than 12 years of Life Sciences research experience; formerly, Dr. Milstein was an European Molecular Biology Organization (EMBO) fellow at NYU’s Skirball Institute of Biomolecular Medicine, where his research provided basic insights into the mechanism of T cell activation. Later in his career, as an NIH fellow at the Scripps Research Institute, he discovered a novel mechanism for iron deficiency anemia. Subsequently, Dr. Milstein focused his research on radiation-induced autoimmune hemolytic anemia.

Dr. Milstein received his Ph.D. degree from The Weizmann Institute of Science in 2008, where he developed novel strategies for successful bone marrow transplantation into irradiated subjects. He received his B.Sc., Magna Cum Laude, from The Hebrew University in Jerusalem. His research has resulted in several peer-reviewed publications and patents.

#OrenMilstein #StemRad #PersonalRadiationProtection #GammaRadiation #Fukushima #Chernobyl #Israel #Nagasaki #Hiroshima #NuclearAccidents #USANCA #CBRN #WMD #DTRA #BoneMarrow #NuclearWar #Putin #Iran #KimJungUn #NASA #LockheedMartin #NationalGuard

Support the Show.